Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.
Information source: National Center for Complementary and Alternative Medicine (NCCAM)
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Post-Traumatic Stress Disorders
Intervention: Slow Breathing (Behavioral); Meditation (Behavioral); Meditation and slow breathing (Behavioral); Sitting Quietly (Behavioral)
Phase: N/A
Status: Recruiting
Sponsored by: Oregon Health and Science University Official(s) and/or principal investigator(s): Helane Wahbeh, ND, Principal Investigator, Affiliation: Oregon Health and Science University
Overall contact: Helane Wahbeh, ND, Phone: (503) 494-3528, Email: wahbehh@ohsu.edu
Summary
The purpose of this study is to find out how meditation influences certain systems in the
body: nervous system, hormonal system, and respiratory system. Another purpose is to see how
meditation may help improve post-traumatic stress disorder symptoms.
Clinical Details
Official title: Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.
Study design: Treatment, Randomized, Single Blind (Investigator), Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Post-traumatic Stress Disorder Checklist: hyper-arousal symptom subscaleAttentional Network Task: conflict effect score Awakening cortisol values
Secondary outcome: Intrusive Thought ScaleEEG event-related negativity during Attentional Network Task Heart rate
Detailed description:
This study requires nine visits to the clinic: one screening visit, one baseline visit, six
training sessions, and one endpoint visit. There will be approximately 100 people enrolled
in this study who will be randomly allocated to one of four groups: a slow breathing group,
a meditation group, a meditation plus slow breathing group and a sitting quietly group.
Participants will undergo a telephone screening, a screening visit, baseline visit, six
intervention visits, and one endpoint visit. A telephone screening and screening visit will
ensure participant eligibility. The screening visit included structured clinician interviews
on PTSD symptoms and other mental health disorders, completion of questionnaires, and
receipt of home saliva collection kit. At the baseline visit, electrodes will be attached to
measure the electrical activity of head, chest, skin, and respiration and blood pressure
during a computer task. Intervention visits include slow breathing, meditation, mediation
and slow breathing, or sitting quietly depending on which group the participant is allocated
to. Breathing rates and other electrical activity of the body will be measured also.
Breathing rate will be measured with an elastic band that is placed around the chest.
Electrical activity will be measured by the electrodes that will be placed on the scalp,
chest and skin. The endpoint visit will be exactly the same as the baseline visit.
Eligibility
Minimum age: 18 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Combat veteran (defined by a score of ≥7 on the Combat exposure scale)
- Chronic PTSD diagnosis
- Age range (18-70 years)
- Both genders
- Good general medical health
- Stable dose of medications for concurrent stable medical conditions for at least 4
weeks prior to start of the study.
- Willing and able to provide informed consent.
Exclusion Criteria:
Significant chronic medical illness including:
• current cancer treatment, unstable angina, recent myocardial infarction, current or past
history of stroke, transient ischemic attack, congestive heart failure, chronic renal or
hepatic failure, hypothyroidism
Psychiatric or behavioral illness including:
• schizophrenia, schizoaffective disorder, bipolar disorder, psychotic disorder (not
including transient dissociative states or flashbacks associated with PTSD re-experiencing
symptoms), any DSM-IV cognitive disorder, current delirium, psychiatric instability or
situational life crises, including evidence of being actively suicidal or homicidal, or
any behavior which poses an immediate danger to the patient or others.
Substance dependence disorder within 3 months of the study or current substance use other
than alcohol (no more than 2 drinks/day by self-report)
Sexual assault as primary PTSD event/s. Planning to move from the area in the next year.
Prior or current meditation practice.
Locations and Contacts
Helane Wahbeh, ND, Phone: (503) 494-3528, Email: wahbehh@ohsu.edu
Oregon Health and Science University, Portland, Oregon 97239, United States; Recruiting Helane Wahbeh, ND, Principal Investigator
Additional Information
Starting date: January 2009
Ending date: September 2013
Last updated: August 13, 2009
|